ARUK-1607

N/A

Report date: 2025/06/11 11:06:08
NME

Base Information

Drug NameARUK-1607
Drug Alias NamePI5P4K inhibitors (University of Cambridge)ARUK-1750ARUK-1607
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 4-kinase inhibitors
TargetsPhosphatidylinositol 4-kinase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesALBORADA Drug Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesALBORADA Drug Discovery Institute
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A